参考文献/References:
[1]付佳,徐琪,韩睿.维生素D及其受体在糖尿病肾病发病中的研究进展[J].中国医药导报,2020,17(7):23-26. [2]Li Q,Feng L,Li J,et al.Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy[J].Endocrine,2013,46(1):83-89. [3]李梦,田少江.Smad1蛋白在糖尿病肾病中的应用与研究进展[J].广东医学,2020,41(12):1294-1296. [4]Oshiro Y,Tanaka H,Kawasaki F,et al.Partial remission by cyclosporine monotherapy in a patient with membranous nephropathy superimposed diabetic nephropathy[J].CEN Case Reports,2016,5(2):219-222. [5]陈武,邹光美.检测血浆25-羟基维生素D水平在糖尿病肾病中的应用价值[J].检验医学与临床,2020,17(13):1850-1853. [6]张健,徐丹丹,王伟涛.胱抑素C、尿微量白蛋白/肌酐比值对早期糖尿病肾病的诊断价值[J].医学信息,2019,32(8):176-177. [7]Miraghajani MS,Esmaillzadeh A,Najafabadi MM,et al.Soy milk consumption, inflammation,coagulation, and oxidative stress among type 2 diabetic patients with nephropathy[J].Diabetes Care,2012,35(10):1981-1985. [8]Seyyed A,Bootorabi M,Ayremlou P,et al.The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial[J].Gynecol Endocrinol,2018,34(6):489-494. [9]Nam H,Kim HY,Choi JS,et al.Association between Serum 25-hydroxyvitamin D Levels and Type 2 Diabetes in Korean Adults[J].Chonnam Medical Journal,2017,53(1):73-77. [10]杨静,傅继华.糖尿病肾病病理机制及治疗措施的研究进展[J].医学研究与教育,2020,37(1):1-6. [11]Wang XM,Yao M,Liu SX,et a1.Interplay between the Notch and P13K/Akt pathways in high glucose induced podocyte apoptosis[J].Am J Physiol Renal Physiol,2014,30(6):205-213. [12]Meng X,Chung AK,Lan H.Role of the TGF-β/BMP-7/Smad pathways in renal diseases[J].Clinical Ence,2013,124(4):243-254. [13]Qu X,Li X,Zheng Y,et al.Regulation of Renal Fibrosis by Smad3 Thr388 Phosphorylation[J].Am J Pathol,2014,184(4):944-952. [14]Das R,Xu S,Quan X,et al.Upregulation of mitochondrial Nox4 mediates TGF -β- induced apoptosis in cultured mouse podocytes[J].Am J Physiol Renal Physiol,2014,306(2):F155. [15]刘俊芬,王琳琳,金玉杰,等.糖尿病肾病患者血清TGFβ/Smad蛋白、p38MAPK蛋白及尿α1-MG水平变化及意义[J].解放军预防医学杂志,2018,36(7):946-947,950. [16]Bi J,Watanabe H,Fujimura R,et al.A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis[J].Scientific Reports, 2018,8(6):3590-3604. [17]蔡凯鹏,谢伟基.骨化三醇对早期糖尿病肾病患者相关炎性因子的影响[J].汕头大学医学院学报,2020,33(2):101-104. [18]李黎.血清1,25-二羟维生素D3超敏C反应蛋白与2型糖尿病肾病的相关性研究[J].中国药物与临床,2020,20(18):3039-3041. [19]陈武,邹光美.检测血浆25-羟基维生素D水平在糖尿病肾病中的应用价值[J].检验医学与临床,2020,17(13):1850-1853. [20]宁聪华,权莉,俞瑞,等.活性维生素D3下调核因子κB炎症通路对2型糖尿病大鼠肝脏保护作用的研究[J].中国糖尿病杂志,2020,28(8):613-618. [21]张爱鸣,厉钗微,高赛赛.C肽及其他因素与2型糖尿病肾病的相关性[J].浙江临床医学,2020,22(5):654-656.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Medical Information,2018,31(01):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Medical Information,2018,31(01):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Medical Information,2018,31(01):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(01):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,31(01):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Medical Information,2018,31(01):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Medical Information,2019,32(01):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Medical Information,2019,32(01):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Medical Information,2019,32(01):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]